An implantable electrode device is provided comprising a first layer and a second layer, the second layer being on top of the first layer and including at least one electrode contact. The at least one electrode contact is exposable to a nerve of a nervous tissue of a human or of an animal. A connecting means electrically connects the electrode contact, where the connecting means is made up of at least one conducting wire, and the conducting wire is arranged within the first layer and is fixed to the electrode contact.

Provided herein is a stimulating device being equipped with an electrode element recording and stimulating nerve signals for diagnosis and treatment of chronic pain or Alzheimer's disease and, most particularly, to a stimulating device providing electrical stimulation for chronic pain or Alzheimer's-causing proteins or measuring bio signals. The stimulating device includes a controller, a substrate being coupled to a bottom of the controller, and having a power receiving and signal delivering electrode being mounted thereon as a single body or being distinctively mounted thereon, wherein the power receiving and signal delivering electrode is capable of wirelessly receiving power and wirelessly delivering bio signals, and an electrode element being coupled to a bottom of the substrate and being capable of delivering electrical stimulation to tissues inside a body.

The present invention relates to endotracheal tubes for intra-operative monitoring of nerve and muscle tissue (neuromonitoring), a system for intra-operative neuromonitoring, a method for deriving stimulus responses in intra-operative neuromonitoring, and a method for classifying tissue types, having the purpose of preventing damage to nerves and muscles which run within the area of operation.

The present invention relates to endotracheal tubes for intra-operative monitoring of nerve and muscle tissue (neuromonitoring), a system for intra-operative neuromonitoring, a method for deriving stimulus responses in intra-operative neuromonitoring, and a method for classifying tissue types, having the purpose of preventing damage to nerves and muscles which run within the area of operation.

A nerve mapping system includes an elongate medical device, a non-invasive mechanical sensor, and a processor. The elongate medical device includes a distal end portion configured to explore an intracorporeal treatment area of a subject, and the distal end portion includes an electrode. The non-invasive mechanical sensor is configured to provide a mechanomyography output signal corresponding to a monitored mechanical response of a muscle innervated by the nerve. The processor is in communication with the electrode and the sensor, and is configured to provide a plurality of electrical stimuli to the electrode. Each of the plurality of stimuli is provided when the electrode is located at a different position within the intracorporeal treatment area. The processor determines the likelihood of a nerve existing at a particular point using the magnitudes of each of the stimuli and the detected response of the muscle.

A nerve mapping system includes an elongate medical device, a non-invasive mechanical sensor, and a processor. The elongate medical device includes a distal end portion configured to explore an intracorporeal treatment area of a subject, and the distal end portion includes an electrode. The non-invasive mechanical sensor is configured to provide a mechanomyography output signal corresponding to a monitored mechanical response of a muscle innervated by the nerve. The processor is in communication with the electrode and the sensor, and is configured to provide a plurality of electrical stimuli to the electrode. Each of the plurality of stimuli is provided when the electrode is located at a different position within the intracorporeal treatment area. The processor determines the likelihood of a nerve existing at a particular point using the magnitudes of each of the stimuli and the detected response of the muscle.

The present invention provides an implantable neuromodulation system for delivering an electrical signal to a nerve to stimulate, inhibit or block conduction of action potentials in the nerve. The system comprises a neural interface device comprising first and second electrodes; a signal generator and a first closed-loop controller configured to generate a control signal based a property of the signal based on a measured voltage across the first and second electrodes, and cause the signal generator to adjust the electrical signal to modify the property of the signal.

The present invention relates to an integrated circuit for processing biosignals, a biosignal processing apparatus, and a biosignal processing system, and the integrated circuit includes: a digital conversion unit for converting an analog biosignal input through a biosignal input terminal into a digital biodata; and an AI block for processing a plurality of biodata converted through the digital conversion unit according to an artificial intelligence processing flow, and outputting a result data according to processing of the plurality of biodata.

An implantable device, or an associated computer program, for estimating a nerve conduction velocity. A stimulus is applied from one or more stimulus electrodes to a nerve. A digitised neural measurement of at least one compound action potential evoked by the at least one stimulus is obtained from one or more recording electrodes by measurement circuitry. The digitised neural measurement comprises a plurality of data sample points. The digitised neural measurement is processed in order to estimate within subsample precision a temporal position of a feature of interest of the compound action potential. From the estimated temporal position of the feature of interest, and from a propagation distance, a conduction velocity of the compound action potential is determined.

An implantable device, or an associated computer program, for estimating a nerve conduction velocity. A stimulus is applied from one or more stimulus electrodes to a nerve. A digitised neural measurement of at least one compound action potential evoked by the at least one stimulus is obtained from one or more recording electrodes by measurement circuitry. The digitised neural measurement comprises a plurality of data sample points. The digitised neural measurement is processed in order to estimate within subsample precision a temporal position of a feature of interest of the compound action potential. From the estimated temporal position of the feature of interest, and from a propagation distance, a conduction velocity of the compound action potential is determined.